<?xml version="1.0" encoding="UTF-8"?>
<p>Naringenin is relatively safe with LD50 of 5000 mg/kg [
 <xref rid="B19-plants-09-01784" ref-type="bibr">19</xref>]. The chief mechanism of action of naringenin is the inhibition of specific cytochrome P450 isoformsâ€”CYP1A2 [
 <xref rid="B20-plants-09-01784" ref-type="bibr">20</xref>] and CYP3A4 in humans [
 <xref rid="B21-plants-09-01784" ref-type="bibr">21</xref>]. Naringenin has successfully demonstrated antagonistic activities on all types of opioid receptors [
 <xref rid="B22-plants-09-01784" ref-type="bibr">22</xref>]. It has positive health effects in humans; concurred by numerous research reports indicating that it has hepatoprotective [
 <xref rid="B23-plants-09-01784" ref-type="bibr">23</xref>], anti-mutagenic [
 <xref rid="B24-plants-09-01784" ref-type="bibr">24</xref>], anti-carcinogenic [
 <xref rid="B25-plants-09-01784" ref-type="bibr">25</xref>], antioxidant [
 <xref rid="B26-plants-09-01784" ref-type="bibr">26</xref>], anti-diabetic [
 <xref rid="B27-plants-09-01784" ref-type="bibr">27</xref>], and antiatherogenic [
 <xref rid="B28-plants-09-01784" ref-type="bibr">28</xref>] activities (
 <xref ref-type="fig" rid="plants-09-01784-f002">Figure 2</xref>). The daily dietary requirement of flavonoids has been considered to be a few hundred milligrams [
 <xref rid="B29-plants-09-01784" ref-type="bibr">29</xref>]. Its role against inflammation and oxidative injuries makes it a potential candidate for the treatment of various oxidative-stress-related disorders [
 <xref rid="B22-plants-09-01784" ref-type="bibr">22</xref>,
 <xref rid="B23-plants-09-01784" ref-type="bibr">23</xref>,
 <xref rid="B24-plants-09-01784" ref-type="bibr">24</xref>,
 <xref rid="B25-plants-09-01784" ref-type="bibr">25</xref>,
 <xref rid="B26-plants-09-01784" ref-type="bibr">26</xref>,
 <xref rid="B27-plants-09-01784" ref-type="bibr">27</xref>,
 <xref rid="B28-plants-09-01784" ref-type="bibr">28</xref>,
 <xref rid="B29-plants-09-01784" ref-type="bibr">29</xref>].
</p>
